Novartis AGFRA:NOT +3.18%83 Forward Dividend Yield % is 3.12% as of Jun. 25, 2026. GuruFocus rates FRA:NOT with a GF Score™ of 83/100 and a GF Value™ of €112.42 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 504 Drug Manufacturers companies, Novartis AG ranks better than 65.08% on this metric.
As of today (2026-06-25), the Forward Annual Dividend Yield of Novartis AG is 3.12%.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Novartis AG is 3.12%.
FRA:NOT's Forward Dividend Yield % is ranked better than 65.08% of 504
companies
in the Drug Manufacturers industry
Industry Median: 2.095
vs FRA:NOT: 3.12
During the past 12 months, Novartis AG's average Dividends Per Share Growth Rate was 3.70% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 0.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 3.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 1.90% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Novartis AG was 18.50% per year. The lowest was 0.00% per year. And the median was 5.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Novartis AG (FRA:NOT) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Novartis AG Forward Dividend Yield % Related Terms
FRA:NOT vs LLY, JNJ, ABBV: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Novartis AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Novartis AG Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Novartis AG's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Novartis AG Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
CHF 3.700000
2026-03-10
2026-03-11
2026-03-12
Cash Dividend
annually
CHF:EUR 1.100703
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Novartis AG's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
4.0726011
/
135.70
=
3.00 %
Current Share Price is €135.70. Novartis AG's Dividends per Share for the forward twelve months is calculated as €4.0726011 * 1 = €4.0726011.
Novartis AG's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
4.0726011
/
135.70
=
3.00 %
Current Share Price is €135.70. Novartis AG's Dividends per Share for the trailing twelve months (TTM) ended in Today is €4.0726011.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 3.12% mean?
Novartis AG (FRA:NOT) has a Forward Dividend Yield % of 3.12% as of Jun. 25, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Novartis AG and its competitors. According to the industry distribution chart, Novartis AG ranks #176 out of 504 companies in the Drug Manufacturers industry, placing it in the top 34.9%.
Is Novartis AG's Forward Dividend Yield % too high?
Novartis AG's current Forward Dividend Yield % is 3.12%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.10. Novartis AG's value of 3.12% is 48.9% above this industry median. Based on the distribution chart, Novartis AG ranks #176 out of 504 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Novartis AG has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novartis AG's Forward Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Novartis AG ranks #176 out of 504 companies for Forward Dividend Yield %. This puts Novartis AG in the upper half of its industry. The industry median Forward Dividend Yield % is 2.10. Novartis AG's value of 3.12% is 48.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.10, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Novartis AG's current Forward Dividend Yield % of 3.12% is 48.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Novartis AG and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Novartis AG's current Forward Dividend Yield % is 3.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novartis AG stock overvalued right now?
Based on GuruFocus' analysis, Novartis AG (FRA:NOT) is currently considered Modestly Overvalued. The stock's GF Value™ is €112.42, compared to a current price of €135.70 — trading 20.7% above its estimated fair value. The current Forward Dividend Yield % is 3.12% and 48.9% above the Drug Manufacturers industry median of 2.10. Novartis AG's overall GF Score™ is 83/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Novartis AG (FRA:NOT), the current Forward Dividend Yield % is 3.12% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Novartis AG (FRA:NOT) Overvalued in 2026?
Based on GuruFocus' analysis, Novartis AG stock appears to be overvalued.
The current stock price of €135.70 is trading 20.7% above its estimated GF Value™ of €112.42.
GuruFocus considers Novartis AG to be Modestly Overvalued.
Key valuation signals for FRA:NOT:
Forward Dividend Yield %: 3.12%
GF Value™: €112.42 vs. price of €135.70 (20.7% above fair value)
Industry Position: 48.9% above the Drug Manufacturers median (#176 of 504)
No single metric tells the full story. See the FRA:NOT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
83GF Score
Get the complete analysis for FRA:NOT
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:NOT has been successfully added to your 